Humacyte, Inc. (HUMA) financial statements (2022 and earlier)

Company profile

Business Address 2525 EAST NORTH CAROLINA HIGHWAY 54
DURHAM, NC 27713
State of Incorp. DE
Fiscal Year End December 31
SIC 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2021
12/31/2020
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:225,5001,095
Cash and cash equivalents217,5021,095
Short-term investments8,000 
Other undisclosed cash, cash equivalents, and short-term investments(2) 
Receivables176 
Prepaid expense3,662149
Other undisclosed current assets2 
Total current assets:229,3401,244
Noncurrent Assets
Finance lease, right-of-use asset21,432 
Operating lease, right-of-use asset727 
Property, plant and equipment35,034 
Long-term investments and receivables 100,016
Long-term investments 100,016
Total noncurrent assets:57,193100,016
TOTAL ASSETS:286,533101,260
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities8,8515
Accounts payable2,0945
Accrued liabilities6,757 
Debt1,981 
Due to related parties 34
Other undisclosed current liabilities218209
Total current liabilities:11,050248
Noncurrent Liabilities
Long-term debt and lease obligation49,152 
Long-term debt, excluding current maturities27,361 
Finance lease, liability21,109 
Operating lease, liability682 
Liabilities, other than long-term debt103,660 
Business combination, contingent consideration, liability103,660 
Other undisclosed noncurrent liabilities4977,998
Total noncurrent liabilities:153,3097,998
Total liabilities:164,3598,246
Temporary equity, carrying amount 88,014
Stockholders' equity
Stockholders' equity attributable to parent, including:122,1745,000
Common stock10 
Additional paid in capital536,7373,580
Retained earnings (accumulated deficit)(414,573)1,420
Other undisclosed stockholders' equity attributable to parent 0
Total stockholders' equity:122,1745,000
TOTAL LIABILITIES AND EQUITY:286,533101,260

Income statement (P&L) ($ in thousands)

12/31/2021
12/31/2020
Operating expenses(82,471) 
Other undisclosed operating income1,263 
Operating loss:(81,208) 
Nonoperating income54,731 
Interest and debt expense3,284 
Net loss:(23,193) 
Other undisclosed net loss attributable to parent(3,284) 
Net loss available to common stockholders, diluted:(26,477) 

Comprehensive Income ($ in thousands)

12/31/2021
12/31/2020
Net loss:(23,193) 
Comprehensive loss:(23,193) 
Other undisclosed comprehensive loss, net of tax, attributable to parent(3,284) 
Comprehensive loss, net of tax, attributable to parent:(26,477) 

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: